Showing results (321-330 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|April 1, 1997
1alpha,25-dihydroxyvitamin D3 activates T cells of tumor bearers through protein phosphatase 2AK M Wiers, Y Lozano, K A Messingham, et al.Cancer Immunology, Immunotherapy : CII|April 1, 1997
p53 serum antibodies as prognostic indicator in head and neck cancerJ A Werner, S Gottschlich, B J Folz, et al.Cancer Immunology, Immunotherapy : CII|April 10, 2002
Immunization with heat shock protein 70 from methylcholanthrene-induced sarcomas induces tumor protection correlating with in vitro T cell responsesAnne-Marie T Ciupitu, Max Petersson, Koji Kono, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1984
Inhibition of lymphocyte mitogenesis by factor(s) released from macrophages isolated from ascitic fluid of advanced ovarian cancer patientsB Sheid, J BoyceCancer Immunology, Immunotherapy : CII|January 1, 1984
The use of cytotoxic T cells in the regulation of tumour growth in syngeneic miceL Kwong, D G Kilburn, H S TehCancer Immunology, Immunotherapy : CII|January 1, 1982
Effects of antibodies to choriogonadotropin in malignant growth. II. Solid transplantable rat tumorsJ A Kellen, A Kolin, A Mirakian, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1982
A quantitative and qualitative study of blood monocytes in patients with bronchogenic carcinomaH Nielsen, J Bennedsen, S O Larsen, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1983
In vivo studies of spleen lymphoid cells implicated in antitumor immunity in hamstersH Haddada, C de Vaux Saint Cyr, A DuthuCancer Immunology, Immunotherapy : CII|January 1, 1984
Studies with a human plasma-derived immunosuppressive, anti-lymphoma factorJ L Farmer, M D PragerCancer Immunology, Immunotherapy : CII|January 1, 1984
The therapeutic significance of concomitant antitumor immunity. I. LY-1-2+ T cells from mice with a progressive tumor can cause regression of an established tumor in gamma-irradiated recipientsR J NorthPageof 650